Tag Archives: Amgen

Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis

(Reuters) – A U.S. judge on Friday upheld two patents relating to Amgen Inc’s blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis AG, which is seeking to launch a copycat version. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file… Read More »

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters. FILE PHOTO: The logo of Lilly is seen… Read More »

Amgen hunts for deals of all sizes to combat forthcoming sales decline

A couple Big Pharma players have come out against megamergers in recent weeks. But Amgen isn’t one of them. On Tuesday’s Q4 earnings conference call, CEO Bob Bradway said his company continues to “look across the waterfront of smaller and larger deals.” “Obviously, there are more smaller ones than larger ones, so we tend to… Read More »